14 Sep 2016 --- Chr. Hansen has signed an agreement with Valio OY to acquire the Finnish company’s LGG business for a cash consideration of €73 million ($82 million). As part of this agreement Chr. Hansen will take over a number of specialty strains already in production and a bacterial collection of around 3,200 strains. In addition, Chr. Hansen and Valio will enter into a strategic research and development collaboration to extract further value within dairy.
